Genome Company announces a clinical trial collaboration and ...
SEOUL, South Korea, Jan. 14, 2020 /PRNewswire-AsiaNet/ -- -- Clinical partnership of phase 1/1b combination clinical trial with Genome & Company's GEN-001, microbiome-based immuno-oncology therapy, and avelumab (BAVENCIO®), Merck KGaA, Darmstadt, Germany and Pfizer Inc.'s anti-PD-L1 antibody in oncology ...
Authors: LATEST ASIANET NEWS RELEASES